New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
A Prospective Study Analyzing Wavefront-Guided LASIK and PRK Surgery Performed by Cornea Fellows in Training.
A Prospective Study Analyzing Wavefront-Guided LASIK and PRK Surgery Performed by Cornea Fellows in Training. Journal of cataract and refractive surgery Chung, M. E., Manche, E. E. 2025Abstract
To evaluate visual outcomes in patients with myopia or compound myopic astigmatism in wavefront-guided laser in situ keratomileusis (WFG-LASIK) and photorefractive keratectomy (WFG-PRK) performed by cornea fellows in training.Academic eye institute in Palo Alto, California, USA.Prospective, nonrandomized clinical trial.Patients with no history of refractive surgery underwent WFG-LASIK or WFG-PRK. Patients had preoperative refractive errors with sphere up to -10.25 diopters (D), cylinder up to 4.50 D, with a maximum spherical equivalent (SE) of -10.00 D. All eyes were targeted for emmetropia. The primary outcome measure was UDVA at 3 months. Secondary outcome measures included safety and predictability.66 eyes of 33 patients underwent WFG-LASIK, and 71 eyes of 36 patients underwent WFG-PRK from March 2017 to October 2024. At 3 months, 91.2% of eyes in the WFG-LASIK group achieved UDVA of 20/20 or better, 35.3% of eyes achieved 20/15 or better, 91.2% of eyes achieved manifest refraction SE (MRSE) within 0.50 D of target, mean SE was -0.04, and no eyes lost more than 2 lines of corrected distance visual acuity (CDVA). In patients who underwent WFG-PRK, 82.0% of eyes achieved UDVA of 20/20 or better, 10.0% of eyes achieved 20/15 or better, 98.0% of eyes achieved MRSE within 0.50 D of target, mean SE was -0.01, and no eyes lost more than 2 lines of CDVA.WFG-LASIK and WFG-PRK performed by cornea fellows in training achieved excellent safety, efficacy, and predictability for the correction of myopia and compound myopic astigmatism.
View details for DOI 10.1097/j.jcrs.0000000000001834
View details for PubMedID 41276956